Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 237

The DOI matches its Crossref record.

Prevalence of Asymptomatic SARS-CoV-2 Infection

Oran, Daniel P., Topol, Eric J. · 2021 · Annals of Internal Medicine

Abstract

LettersFebruary 2021Prevalence of Asymptomatic SARS-CoV-2 InfectionFREEDaniel P. Oran, AM, Eric J. Topol, MDDaniel P. Oran, AMScripps Research Translational Institute, Scripps Research La Jolla, CaliforniaSearch for more papers by this author, Eric J. Topol, MDScripps Research Translational Institute, Scripps Research La Jolla, CaliforniaSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/L20-1285 SectionsAboutVisual AbstractPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:In our view, Dr. Halperin does not fairly characterize the evidence of asymptomatic transmission presented by Lavezzo and colleagues (1) concerning their research in Vo’, Italy. Lavezzo and colleagues state, “The presence of a significant number of asymptomatic SARS-CoV-2 infections raises questions about their ability to transmit the virus. To address this issue, we conducted an extensive contact tracing analysis of the 8 new infections.” After describing the various contacts of the infected persons, Lavezzo and colleagues conclude, “These results suggest that asymptomatic infections may play a key role in the transmission of SARS-CoV-2.”The following is the complete sentence from our review cited by Dr. Halperin: “The early data that we have assembled on the prevalence of asymptomatic SARS-CoV-2 infection suggest that this is a significant factor in the rapid progression of the COVID-19 pandemic.” From our perspective, it seems that Dr. Halperin has inferred a far more extreme interpretation than our actual words are meant to convey. We stress that the data are early, not definitive. We describe them as suggestive, not conclusive.We are puzzled by the critique of Dr. Cevik and associates. In the opening paragraphs of our review, we clearly state that most of the data sets were cross-sectional in nature. In our table, we took care in labeling the minority of data sets that included longitudinal data. We also clearly explained the ambiguity surrounding asymptomatic versus presymptomatic status.The “systematic review” preprint (2) that Dr. Cevik and associates cite appeared after our article was published. In our opinion, this review fails to adequately address the compelling study that it included from Vo’, Italy, which we also included. Not only does this study contain a large representative sample with longitudinal data, but its findings are supported by other data sets that we included. The study was completed over 14 days, and the investigators concluded that the proportion of asymptomatic persons was 42.2%. In addition, none of the participants who was asymptomatic at the beginning of the study had developed symptoms by the end.None of the sources cited by Drs. Han and Li present data that were collected from representative samples. In contrast, 3 of the studies that we included in our review are the result of representative samples, and 1 of these has the added benefit of longitudinal data from a 14-day period. We were impressed by the narrow range reported in these studies for the proportion of asymptomatic infected persons: between 42.2% and 44.8%. However, in the absence of longitudinal data for 2 of these studies and because of the resulting uncertainty concerning the possible admixture of presymptomatic persons, we suggested that 30% is a conservative estimate.Drs. Cohen and Kessel are concerned about a potentially high false-positive rate for RT-PCR testing for SARS-CoV-2. Large-scale testing programs in China would seem to be instructive. Between 14 May and 1 June 2020 in Wuhan, public health officials tested 9 899 828 persons, which represented 92.9% of those older than 6 years (3); a total of 300 persons received positive results. In October 2020 in Qingdao, 10.9 million persons were tested (4); of these, 9 persons received positive results.Even if one were to assume that all of these positive test results were erroneous, that would mean that, as a fraction of total tests performed, 0.003% of the tests in Wuhan and 0.00008% of those in Qingdao were false-positives. This real-world evidence seems to be at odds with the studies cited by Drs. Cohen and Kessel, which are based on considerably smaller data sets. Clearly, more research is needed on this topic.We assembled the data in our review in April and May 2020, beginning approximately 3 months after the first reports of illness caused by a novel coronavirus. Our review, which was published on 3 June, was our best effort to present and interpret those early data. We believe that it scrupulously adheres to the principles of “accurate reporting, prudence, and restraint” suggested by Dr. Elder.Like so much else associated with SARS-CoV-2, the finer points of infectiousness and asymptomatic transmission are still, as of this writing in October 2020, hardly settled matters. According to the Centers for Disease Control and Prevention, “Recovery of replicatio

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/l20-1285

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 3

  1. 10.1038/s41467-020-19802-w · DOI
  2. 10.1056/NEJMc2032361 · DOI
  3. 10.7554/eLife.58699 · DOI

Cited by

See all 237

Metadata

Authors
Oran, D. P., & Topol, E. J.
Venue
Annals of Internal Medicine
Published
2021-02
Volume
174
Issue
2
Pages
286-287
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W3032252754
Cited by
237
References
0
FWCI
11.99
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevalence of Asymptomatic SARS-CoV-2 Infection. https://app.cochat.ai/papers/10.7326/l20-1285
The paper
Oran, D. P., & Topol, E. J. (2021). Prevalence of Asymptomatic SARS-CoV-2 Infection. Annals of Internal Medicine. https://doi.org/10.7326/l20-1285

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.